Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.


In the field of oncology, clinical molecular diagnostics and biomarker discoveries are constantly advancing as the intricate molecular mechanisms that transform a normal cell into an aberrant state in concert with the dysregulation of alternative complementary pathways are increasingly understood. Progress in biomarker technology, coupled with the companion… (More)
DOI: 10.1586/erm.12.59


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics